4//SEC Filing
Urist Marshall 4
Accession 0001802768-24-000047
CIK 0001802768other
Filed
Aug 11, 8:00 PM ET
Accepted
Aug 12, 7:17 PM ET
Size
7.0 KB
Accession
0001802768-24-000047
Insider Transaction Report
Form 4
Urist Marshall
EVP, Research & Investments
Transactions
- Gift
LP interests in RPI US Partners 2019, LP
2024-08-12−2,182→ 126,412 total(indirect: By LLC)→ Class A Ordinary Shares (21,820 underlying)
Footnotes (3)
- [F1]No limited partnership interests in RPI US Partners 2019, LP ("RPI US LP") are being exchanged by the Reporting Person. Each limited partnership interest in RPI US LP ("RPI US LP Interest") may be exchanged for ten Class B Interests in Royalty Pharma Holdings Limited ("Holdings"). Each Class B Interest in Holdings so distributed will be exchanged for one Class A Ordinary Share of the Issuer. Any exchanges will be made pursuant to the terms of the Exchange Agreement dated June 16, 2020, among the Issuer, Holdings, RPI US LP, RPI International Holdings 2019, LP, RPI International Partners 2019, LP and RPI EPA Holdings, LP (the "Exchange Agreement"). No additional value will be paid by the Reporting Person in connection with an exchange.
- [F2]The Reporting Person made a charitable donation of RPI US LP Interests. No Class A Ordinary Shares or RPI US LP Interests were sold.
- [F3]Represents RPI US LP Interests. Each RPI US LP Interest can be exchanged for ten Class B Interests in Holdings at any time and for no additional value, which exchange right does not expire until so converted. Upon such exchange, each Class B Interest in Holdings issued in exchange for a RPI US LP Interest will be exchanged for one Class A Ordinary Share of the Issuer for no additional value.
Documents
Issuer
Royalty Pharma plc
CIK 0001802768
Entity typeother
Related Parties
1- filerCIK 0001838139
Filing Metadata
- Form type
- 4
- Filed
- Aug 11, 8:00 PM ET
- Accepted
- Aug 12, 7:17 PM ET
- Size
- 7.0 KB